Mieszko Lachota

9PUBLICATIONS
41CO-AUTHORS
GlycoconjugatesBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 25, 2024
The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration.

Daniel Palacios, Rakesh Kumar Majhi, Edina K Szabo

|Jan 11, 2024
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence.

Agata Czaplicka, Mieszko Lachota, Leszek Pączek

|Dec 02, 2021
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Marta Klopotowska, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka

|Jul 01, 2021
Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.

Mieszko Lachota, Anton Lennikov, Karl-Johan Malmberg

|Dec 16, 2020
Prospects for NK Cell Therapy of Sarcoma.

Mieszko Lachota, Marianna Vincenti, Magdalena Winiarska

Pageof 2